Navigation Links
BT For Life Sciences Launches Schrodinger Into The Cloud
Date:5/3/2013

IRVING, Texas, May 3, 2013 /PRNewswire/ -- BT and Schrodinger, Inc. today announced that the two companies are now working together to accelerate the process of drug discovery and development using the BT for Life Sciences cloud platform and Schrodinger's powerful scientific software applications.

As part of the joint initiative, Schrodinger becomes a Strategic Member of the BT for Life Sciences partner ecosystem, helping provide research solutions to scientists on a global basis. Schrodinger's software tools will be integrated into BT for Life Sciences as part of BT's R&D Workbench environment. Built on the BT Cloud Compute platform and unveiled at the 10th Annual BioIT World meeting last year, BT for Life Sciences is the first cloud service designed to enable collaboration within the life sciences industry for increased productivity in discovery, research and development.

One of Schrodinger's key applications, hosted Seurat, will soon be available on the BT Cloud Compute Platform. This application contains tools that help researchers in the discovery and optimization of drug research and provides a means for sharing real-time analysis across the organization. Using the BT platform, Schrodinger can easily integrate data and scientific business processes, enhancing the early discovery process so that ultimately better compounds can be brought to the clinic faster.

Because BT for Life Sciences was developed as a secure and segregated platform for scientists, it will enable Schrodinger to work with major pharmaceutical companies and other biotech organizations that need faster and more innovative approaches to drug discovery and development.  In the past, researchers would typically provide the IT department with the requirements for each in silico experiment, which could mean a delay in research and discovery as the equipment was purchased and the platform built.  Using BT's cloud
'/>"/>

SOURCE BT
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
3. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
5. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
6. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
7. Neurocrine Biosciences Reports First Quarter 2012 Results
8. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
9. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
10. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
11. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... India , September 4, 2015 ... 2015 Market Research Report is a professional and ... global Surgical Gown industry with a focus on ... take 2-3 working days once an order is ... market spread across 150 pages, analyzing and profiling ...
(Date:9/4/2015)... PLAINFIELD, N.J. , Sept. 4, 2015 /PRNewswire/ ... pleased to announce five recipients of its first-ever ... Realize Innovation, Vision and Empowerment), designed to aid ... Duchenne muscular dystrophy (DMD) community. The announcement is ... the international World Duchenne Awareness Day on Monday, ...
(Date:9/4/2015)... , Sept. 4, 2015  Allergan plc (NYSE: AGN ... Brent Saunders , CEO and President of Allergan, will provide ... Morgan Stanley Global Healthcare Conference 2015 in New ... The presentation will take place on ... the Grand Hyatt New York, 109 East 42nd Street, ...
Breaking Medicine Technology:Surgical Gown Market 2020 Forecasts With a Focus on China 2Surgical Gown Market 2020 Forecasts With a Focus on China 3Surgical Gown Market 2020 Forecasts With a Focus on China 4PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3
... , ARDEE, Ireland, Dec. 11 As Warner ... its acquisition of the global branded prescription pharmaceuticals business ... 30, 2009 (the "PGP Acquisition"), constituted a change of ... "Marketing Agreement") between a P&G subsidiary acquired by Warner ...
... , LONDON and PHILADELPHIA, Dec. 11 ... breast cancer experienced a median survival of 14 months when ... (trastuzumab). The results of the Phase III study in HER2-positive ... San Antonio Breast Cancer Symposium, held in San Antonio, Texas ...
Cached Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 2GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 3GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 5GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 6
(Date:9/4/2015)... ... September 04, 2015 , ... Keeping mold top of mind is ... is quite common. Mold can grow anywhere - on carpet, clothing, food, paper, and ... excessive moisture and water in the home is key to preventing mold growth, which ...
(Date:9/4/2015)... ... ... Mike Day, a former Navy SEAL who was shot 27 times during ... Kona on October 10th. , Mike is running the race to raise awareness and ... cutting-edge treatments that restore their quality of life. More than 300,000 post ...
(Date:9/4/2015)... ... September 04, 2015 , ... The USC Eye Institute ... number 9 nationwide by Doximity. Faculty, residents and staff are honored to have ... in the quality of our ophthalmology residency program. Our faculty places a high priority ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... development of its first neighborhood created specifically for adults with intellectual, developmental and ... Phoenix Metro area and feature 30 cottage or “pocket” homes. In this community, ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... comparison to settlements under the Stark physician self-referral law. “Stark Law DOs ... webinar from Atlantic Information Services, Inc. (AIS), will detail which deals are attracting ...
Breaking Medicine News(10 mins):Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2
... In a study conducted by Dr Taraneh Dean of the University ... being unnecessarily restricted // in their food intakes ... types foods. The team found that found that 54 per cent ... certain foods because their parents were convinced that such food ...
... a vine is thought to possess properties very close to insulin, ... . This discovery has been made by DIA-B, a biotech company ... ,The company is yet to apply for a patent, so ... the bark. ,To quote Dr Wooldridge, 'The medical and ...
... According to a recent study conducted by McGill University in ... healthy bones and also prevents cancer // . The sun ... cancer, breast cancer and prostate cancer. It was also found ... birth to smaller babies. Experts from Canada, US and Australia ...
... come for emergency treatment at Victoria Hospital in Bangalore were ... at the hospital is said to be struggling to accommodate ... has been further worsened with one of the wings of ... months. ,He hospital sources have said that the ...
... on British men has found that 96 perc ent of them ... a means to distress //. ,The survey done on ... vitamin supplement manufacturer, Vitabiotics ,and found that 22 percent of ... ,The findings also revealed that 28 percent of ...
... Health Information has found that although men experience more heart attacks, ... The study also found that women are at an increased risk ... first time we know there's a difference. Now we have to ... vice president of research and analysis for the Canadian Institute for ...
Cached Medicine News:Health News:Role of Vitamin D in Preventing Cancer 2Health News:Victoria Hospital In Bangalore is Lacking Beds In Emergency wards 2
3.5v Ophthalmic Diagnostic Set with Diagnostic Ophthalmoscope, Spot Retinoscope, Rechargeable Handle, and Soft Case. High-quality eyecare from the preferred name in diagnostic instruments....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
The Welch Allyn 125 BIO is designed to achieve precise binocular viewing and stereopsis easier than ever before. Its observation paths can be adjusted from 48 mm to 74 mm to handle the widest and nar...
Medicine Products: